This Article Full Text Full Text (PDF) Correction (v67,p1877) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hahn, T. Articles by Akporiaye, E. T. Search for Related Content PubMed PubMed Citation Articles by Hahn, T. Articles by Akporiaye, E. T.

Dietary Administration of the Proapoptotic Vitamin E Analogue -Tocopheryloxyacetic Acid Inhibits Metastatic Murine Breast Cancer

Departments of ¹ Immunobiology and ² Chemistry and ³ College of Pharmacy, Arizona Cancer Center, BIO5 Institute for Collaborative Bioresearch, Department of Chemistry, University of Arizona, Tucson, Arizona

Requests for reprints: Emmanuel T. Akporiaye, Department of Immunobiology, University of Arizona, 1501 North Campbell Avenue, Tucson, AZ 85724. Phone: 520-626-6859; Fax: 520-626-2100; E-mail: akporiay{at}email.arizona.edu.

The ability of the vitamin E (RRR--tocopherol) derivatives -tocopheryl succinate (-TOS) and -tocopheryloxyacetic acid (-TEA) to suppress tumor growth in preclinical animal models has recently led to increased interest in their potential use for treating human cancer. To make the use of these vitamin E analogues more clinically relevant, we compared the antitumor efficacy of orally and i.p. delivered forms of -TEA and -TOS against a murine mammary cancer (4T1) that bears resemblance to human breast cancer because of its poor immunogenicity and high metastatic potential. In cell culture studies, we showed that both compounds inhibited tumor colony formation and induced apoptotic death of tumor cells. To avoid solubility concerns associated with the hydrophobicity of -TEA and -TOS, we used the vesiculated forms of -TEA (V-TEA) and -TOS (V-TOS) for the in vivo tumor studies. Both compounds inhibited the growth of preestablished 4T1 tumors when given i.p. However, when given by oral gavage, only the esterase-resistant V-TEA was able to suppress primary tumor growth and reduce lung metastasis. To make this approach more translatable to the clinic, -TEA was incorporated into the diet and fed to tumor-bearing mice. We report here for the first time that dietary -TEA delivery significantly inhibited primary tumor growth and dramatically reduced spontaneous metastatic spread to the lung in prophylactic and therapeutic settings. This study suggests that dietary -TEA could prove useful as a relatively easy and effective modality for treating metastatic breast cancer. (Cancer Res 2006; 66(19): 9374-8)

This article has been cited by other articles:

				P. Latimer, M. Menchaca, R. M. Snyder, W. Yu, B. E. Gilbert, B. G. Sanders, and K. Kline Aerosol Delivery of Liposomal Formulated Paclitaxel and Vitamin E Analog Reduces Murine Mammary Tumor Burden and Metastases Experimental Biology and Medicine, October 1, 2009; 234(10): 1244 - 1252. [Abstract] [Full Text] [PDF]

				P.-H. Huang, D. Wang, H.-C. Chuang, S. Wei, S. K. Kulp, and C.-S. Chen {alpha}-Tocopheryl succinate and derivatives mediate the transcriptional repression of androgen receptor in prostate cancer cells by targeting the PP2A-JNK-Sp1-signaling axis Carcinogenesis, July 1, 2009; 30(7): 1125 - 1131. [Abstract] [Full Text] [PDF]

				T. Hahn, K. Fried, L. H. Hurley, and E. T. Akporiaye Orally active {alpha}-tocopheryloxyacetic acid suppresses tumor growth and multiplicity of spontaneous murine breast cancer Mol. Cancer Ther., June 1, 2009; 8(6): 1570 - 1578. [Abstract] [Full Text] [PDF]

				L.-F. Dong, R. Freeman, J. Liu, R. Zobalova, A. Marin-Hernandez, M. Stantic, J. Rohlena, K. Valis, S. Rodriguez-Enriquez, B. Butcher, et al. Suppression of Tumor Growth In vivo by the Mitocan {alpha}-tocopheryl Succinate Requires Respiratory Complex II Clin. Cancer Res., March 1, 2009; 15(5): 1593 - 1600. [Abstract] [Full Text] [PDF]

				J. Ni, T. Mai, S.-T. Pang, I. Haque, K. Huang, M. A. DiMaggio, S. Xie, N. S. James, D. Kasi, S. R. Chemler, et al. In vitro and In vivo Anticancer Effects of the Novel Vitamin E Ether Analogue RRR-{alpha}-Tocopheryloxybutyl Sulfonic Acid in Prostate Cancer Clin. Cancer Res., February 1, 2009; 15(3): 898 - 906. [Abstract] [Full Text] [PDF]

				L.-F. Dong, E. Swettenham, J. Eliasson, X.-F. Wang, M. Gold, Y. Medunic, M. Stantic, P. Low, L. Prochazka, P. K. Witting, et al. Vitamin E Analogues Inhibit Angiogenesis by Selective Induction of Apoptosis in Proliferating Endothelial Cells: The Role of Oxidative Stress Cancer Res., December 15, 2007; 67(24): 11906 - 11913. [Abstract] [Full Text] [PDF]

				Inhibition of Murine Breast Cancer Using Dietary {alpha}-TEA Cancer Res., February 15, 2007; 67(4): 1877 - 1877. [Full Text] [PDF]